CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $85,000 | -25.4% | 41,932 | 0.0% | 0.00% | – |
Q4 2021 | $114,000 | -41.5% | 41,932 | -4.0% | 0.00% | – |
Q3 2021 | $195,000 | -15.2% | 43,691 | +10.3% | 0.00% | – |
Q2 2021 | $230,000 | -8.7% | 39,594 | +10.3% | 0.00% | -100.0% |
Q1 2021 | $252,000 | +51.8% | 35,905 | +3.9% | 0.00% | – |
Q4 2020 | $166,000 | +2.5% | 34,573 | +24.4% | 0.00% | – |
Q3 2020 | $162,000 | -4.1% | 27,792 | +10.7% | 0.00% | – |
Q2 2020 | $169,000 | +7.6% | 25,103 | +1.6% | 0.00% | – |
Q1 2020 | $157,000 | -39.1% | 24,705 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $258,000 | +226.6% | 24,705 | +23.2% | 0.00% | – |
Q3 2019 | $79,000 | -98.6% | 20,051 | -94.7% | 0.00% | -100.0% |
Q2 2019 | $5,617,000 | -25.4% | 377,777 | +24.5% | 0.01% | -29.4% |
Q1 2019 | $7,533,000 | -43.1% | 303,475 | -58.8% | 0.02% | -48.5% |
Q4 2018 | $13,240,000 | -41.1% | 737,188 | -3.7% | 0.03% | -28.3% |
Q3 2018 | $22,486,000 | -22.9% | 765,620 | +19.3% | 0.05% | -25.8% |
Q2 2018 | $29,172,000 | +2.8% | 641,570 | +19.4% | 0.06% | +1.6% |
Q1 2018 | $28,377,000 | -3.8% | 537,456 | +23.8% | 0.06% | 0.0% |
Q4 2017 | $29,512,000 | -12.9% | 433,999 | +5.6% | 0.06% | -16.4% |
Q3 2017 | $33,867,000 | +85.5% | 411,010 | +110.8% | 0.07% | +78.0% |
Q2 2017 | $18,255,000 | +55.0% | 194,969 | +5.4% | 0.04% | +51.9% |
Q1 2017 | $11,776,000 | +2025.6% | 184,961 | +1383.4% | 0.03% | +2600.0% |
Q4 2016 | $554,000 | +6.1% | 12,469 | -13.9% | 0.00% | 0.0% |
Q3 2016 | $522,000 | +162.3% | 14,489 | 0.0% | 0.00% | – |
Q2 2016 | $199,000 | -13.9% | 14,489 | +20.7% | 0.00% | -100.0% |
Q1 2016 | $231,000 | -45.0% | 12,006 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $420,000 | -96.8% | 12,006 | -91.5% | 0.00% | -97.0% |
Q3 2015 | $13,007,000 | +36.3% | 141,445 | +30.3% | 0.03% | +50.0% |
Q2 2015 | $9,541,000 | -25.4% | 108,570 | -37.0% | 0.02% | -21.4% |
Q1 2015 | $12,785,000 | -4.3% | 172,248 | -27.8% | 0.03% | -6.7% |
Q4 2014 | $13,354,000 | +14.6% | 238,472 | -7.2% | 0.03% | +15.4% |
Q3 2014 | $11,653,000 | +36.1% | 256,897 | +24.2% | 0.03% | +30.0% |
Q2 2014 | $8,565,000 | -5.2% | 206,835 | +58.6% | 0.02% | -4.8% |
Q1 2014 | $9,034,000 | +1395.7% | 130,415 | +1201.2% | 0.02% | +2000.0% |
Q4 2013 | $604,000 | +11.2% | 10,023 | +12.2% | 0.00% | 0.0% |
Q3 2013 | $543,000 | -9.3% | 8,936 | 0.0% | 0.00% | -50.0% |
Q2 2013 | $599,000 | – | 8,936 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |